Beilstein J. Org. Chem. 2016, 12, 863–873.
2H), 5.59 (d, J = 5.1 Hz, 2H); 13C NMR (101 MHz, DMSO-d6) 135.75, 132.61, 129.94, 129.67, 129.17, 126.34, 126.19, 125.58,
δ 149.97, 147.61, 143.07, 141.07, 140.46, 136.13, 131.72, 120.66, 116.95, 112.75, 54.12, 43.41; Anal. calcd for
130.09, 129.27, 128.74, 128.50, 128.30, 127.73, 125.73, 125.50, C42H34Cu2F12N14P2: C, 43.80; H, 2.98; N, 17.02; found: C,
117.68, 116.38, 114.80, 53.42, 42.83.
43.51; H, 2.85; N, 16.95.
Synthesis of 3-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-1- Synthesis of [Cu2(L3)2](PF6)2 (4): The compound was pre-
(pyridin-2-ylmethyl)-1H-benzo[d]imidazol-3-ium hexa- pared similarly as for complex 3 from [HL3](PF6) (90 mg,
fluorophosphate [(HL5)PF6] (1e): Similarly as described in 0.20 mmol) with copper powder (64 mg, 1.0 mmol) at 50 °C for
previous procedure [27], the imidazolium salt was prepared 10 h, orange yellow solid. Yield: 71 mg, 68%. 1H NMR
similarly as for [(HL3)PF6] from (azidomethyl)benzene (600 MHz, acetonitrile-d3) δ 7.96 (s, 1H, triazole), 7.90 (br, 1H,
(160 mg, 1.2 mmol), and 3-(prop-2-yn-1-yl)-1-(pyridin-2- 2-py), 7.83 (br, 1H, imidazole), 7.76 (s, 1H, 4-py), 7.57 (br, 1H,
ylmethyl)-1H-benzo[d]imidazol-3-ium bromide (328 g, imidazole), 7.41 (s, 1H, 5-py), 7.37 (d, J = 7.8 Hz, 3H, phenyl),
1 mmol). Yield: 390 mg, 74%.1H NMR (400 MHz, DMSO-d6) 7.30–7.22 (m, 3H, phenyl + 3-py), 5.47 (s, 2H), 5.38 (s, 2H);
δ 10.04 (s, 1H, NCHN), 8.46 (d, J = 4.8 Hz, 1H, 2-Py), 8.39 (s, 13C NMR (151 MHz, acetonitrile-d3) δ 181.20 (Cu-C), 149.68,
1H, triazole), 8.10 (d, J = 8.0 Hz, 1H, 4-Py), 7.94–7.90 (m, 3H), 147.26, 140.72, 138.41, 134.71, 129.02, 128.89, 128.80, 128.28,
7.73–7.59 (m, 3H), 7.46–7.27 (m, 6H, phenyl+benzene), 5.95 128.04, 123.96, 123.48, 112.13, 54.36, 45.69; Anal. calcd for
(s, 4H, CH2), 5.63 (s, 2H, CH2);13C NMR (101 MHz, DMSO- C36H32Cu2F12N12P2: C, 41.19; H, 3.07; N, 16.01; found: C,
d6) δ 153.34, 150.04, 143.67, 140.07, 138.02, 136.14, 131.80, 41.25; H, 3.31; N, 15.46.
131.29, 129.27, 128.74, 128.48, 127.33, 127.16, 125.33, 124.19,
123.20, 114.48, 114.41, 53.5, 51.4, 42.3.
Synthesis of [Cu3(L4)3](PF6)3 (5): The compound was pre-
pared similarly as for complex 3 from [HL4](PF6) (106 mg,
General procedure for the preparation of Cu(I)–NHC com- 0.20 mmol) with copper powder (64 mg, 1.0 mmol) at 50 °C for
plexes and Cu(II) complex: Analogously as described in [39], 10 h, light yellow solid. Yield: 93 mg, 52%. 1H NMR
all the copper complexes were prepared by the following route: (600 MHz, acetone-d6) δ 8.77 (d, J = 8.1 Hz, 1H, 2-py), 8.46
imidazolium salt (0.2 mmol) and an excess of copper powder (td, J = 8.0, 1.8 Hz, 1H, 4-py), 8.33 (s, 1H, triazole), 8.23–8.20
(64 mg, 1.0 mmol) were placed in 3 mL of MeCN to form a (m, 1H), 7.90 (dd, J = 5.1, 1.5 Hz, 1H, benzimidazole),
heterogeneous mixture solution. After the mixture was stirred at 7.84–7.81 (m, 1H, benzimidazole), 7.68–7.60 (m, 2H, benz-
50 °C for 10 h under air, the solution was filtered through imidazole), 7.44 (dd, J = 7.6, 5.0 Hz, 1H, 5-py), 7.33–7.31 (m,
Celite. Single crystals suitable for X-ray diffraction analysis 3H, phenyl), 6.94–6.92 (m, 2H, phenyl), 5.84 (d, J = 15.8 Hz,
were grown from acetonitrile solution and diethyl ether.
1H), 5.37 (d, J = 15.8 Hz, 1H), 5.18 (s, 2H); 13C NMR
(151 MHz, DMSO-d6) δ 178.99 (Cu-C), 149.61, 148.44,
Synthesis of [Cu-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)-3- 142.25, 140.55, 136.19, 134.91, 133.34, 129.31, 128.93, 128.09,
( p y r i m i d i n - 2 - y l ) - 1 , 3 - d i h y d r o - 2 H - i m i d a z o l - 2 - 126.05, 125.82, 124.48, 124.27, 119.09, 118.51 (CH3CN),
one)2](PF6)2 (2): This complex was synthesized by the reac- 112.74, 111.59, 54.13, 41.17, 1.56(CH3CN); Anal. calcd for
tion of [H(L1)](PF6) (1a; 93 mg, 0.2 mmol) with copper powder C132H108Cu6F36N36P6. 3CH3CN: C, 46.39; H, 3.30; N, 15.29;
(64 mg, 1.0 mmol) at 50 °C for 10 h. Yield: 79 mg (75%), light found: C, 45.87; H, 3.40; N, 15.30.
green crystals. Anal. calcd for C34H30CuF12N14O2P2. 0.5
CH3CN: C, 40.39; H, 3.05; N, 19.52; found: C, 40.73; H, 2.95; Synthesis of [Cu3(L5)3](PF6)3 (6): The compound was pre-
N, 19.15.
pared similarly as for complex 3 from [HL5](PF6) (106 mg,
0.20 mmol) with copper powder (64 mg, 1.0 mmol) at 50 °C for
Synthesis of [Cu2(L2)2](PF6)2 (3): This complex was synthe- 10 h, light yellow solid. Yield: 106 mg, 90%. 1H NMR
sized by the reaction of [HL2](PF6) (1b; 102 mg, 0.2 mmol) (600 MHz, nitromethane-d3) δ 8.13 (s, 1H, triazole), 7.92 (td,
with copper powder (64 mg, 1.0 mmol) at 50 oC for 10 h. Yield: J = 7.8, 1.8 Hz, 1H, pyridine), 7.77 (d, J = 7.8 Hz, 1H,
66 mg (57%), red crystals. 1H NMR (600 MHz, acetonitrile-d3) pyridine), 7.59 (d, J = 7.8, 1H, pyridine), 7.61–7.36 (m, 6H,
δ 8.75 (d, J = 8.1 Hz, 2H, benzimidazole), 8.70 (d, J = 4.9 Hz, phenyl + benzimidazole), 7.14–7.08 (m, 2H, benzimidazole),
4H, pyrimidine), 7.88 (s, 2H, triazole), 7.79 (d, J = 7.8 Hz, 2H, 6.95 (ddd, J = 7.5, 5.2, 1.1 Hz, 1H, pyridine), 6.49–6.45 (d,
benzimidazole), 7.59–7.54 (m, 2H, benzimidazole), 7.52 (t, J = 4.8 Hz,1H, benzimidazole), 5.40 (d, J = 15.0 Hz, 1H, -CH2-
J = 7.2 Hz, 2H, benzimidazole), 7.36 (t, J = 4.9 Hz, 2H, pyrimi- ), 5.30 (d, J = 15.0 Hz, 1H, -CH2-), 5.27 (d, J = 15.0 Hz, 1H,
dine), 7.31–7.29 (m, 6H, phenyl), 7.19–7.18 (m, 4H, phenyl), -CH2-), 5.26 (d, J = 15.6 Hz, 1H, -CH2-), 5.21 (d, J = 15.0 Hz,
5.61 (s, 4H, -CH2-), 5.38 (s, 4H, -CH2-); 13C NMR (151 MHz, 1H, -CH2-), 4.98 (d, J = 15.6 Hz, 1H, -CH2-); 13C NMR
acetonitrile-d3) δ 191.23 (Cu-C), 158.73, 157.33 142.39, 136.17 (150 MHz, nitromethane-d3) 177.57 (Cu-C), 151.99, 148.85,
870